Norinnova Invest is a venture capital and private equity firm investing in research-based and technology companies operating in Norway that is headquartered in Tromso, Norway and was founded in 2007. The firm looks for companies with technologies backed by research, active ownership, collaborative competence environments, commercial expertise, and international networks.
The firm uses seed and early-stage funds funded in Oslo, Stavanger, Bergen and Trondheim to make their investments. Norinnova Invest has approximately NOK 96.5 million in private capital, and has an additional subordinated loan worth NOK 175 million from Innovation Norway. As of November 2019 the firm has made 38 investments, has 12 companies in its portfolio, and has made 6 exits since its founding.
Notable investments made by Norinnova Invest include: Arena Norge, Lytix Biopharma, Dualog, Lyfstone, Amicoat, Vitux Group, Pharma Holdings, Calanus, Prophylix Pharma, Preecap, and Resight.
